Literature DB >> 19110247

A twin study of heritability of plasma lipoprotein-associated phospholipase A2 (Lp-PLA2) mass and activity.

Livia Lenzini1, Katia Antezza, Brasilina Caroccia, Robert L Wolfert, Radoslaw Szczech, Maurizio Cesari, Krzysztof Narkiewicz, Christopher J Williams, Gian Paolo Rossi.   

Abstract

OBJECTIVE: We investigated heritability of plasma levels (mass) and activity of lipoprotein-associated phospholipase A(2) (Lp-PLA(2)).
MATERIALS AND METHODS: In 54 healthy twins pairs we estimated genetic variance and heritability of Lp-PLA(2) mass and activity using maximum likelihood and least squares methods. We estimated intra-class correlation (ICC) and proportion of additive genetic variance from a model comprising additive genetic influence (A), environmental effect common to cotwins (C) and individually unique environmental (E) influence (ACE) model.
RESULTS: Twenty-six twin pairs were monozygotic (MZ) and 28 dizygotic (DZ). The Lp-PLA(2) mass and activity showed a significant correlation (r=0.87, p<0.001) and the mean values were similar in MZ and DZ. ICC estimates of heritability for Lp-PLA(2) were 0.27 (mass) and 0.28 (activity); ACE model-based estimates of heritability were 0.37 (mass) and 0.54 (activity). Heritability estimates were not significant for Lp-PLA(2) mass, but significant for Lp-PLA(2) activity.
CONCLUSIONS: These results suggest heritability for activity, but not for mass, in healthy Caucasians.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19110247     DOI: 10.1016/j.atherosclerosis.2008.08.045

Source DB:  PubMed          Journal:  Atherosclerosis        ISSN: 0021-9150            Impact factor:   5.162


  8 in total

1.  Lipoprotein-associated phospholipase A2 and risk of incident cardiovascular disease in a multi-ethnic cohort: The multi ethnic study of atherosclerosis.

Authors:  Parveen K Garg; Robyn L McClelland; Nancy S Jenny; Michael H Criqui; Philip Greenland; Robert S Rosenson; David S Siscovick; Neal Jorgensen; Mary Cushman
Journal:  Atherosclerosis       Date:  2015-05-16       Impact factor: 5.162

Review 2.  Lipoprotein-associated phospholipase A2 prognostic role in atherosclerotic complications.

Authors:  Giuseppe Maiolino; Valeria Bisogni; Giacomo Rossitto; Gian Paolo Rossi
Journal:  World J Cardiol       Date:  2015-10-26

3.  Residual atherosclerotic cardiovascular disease risk in statin-treated adults: The Multi-Ethnic Study of Atherosclerosis.

Authors:  Nathan D Wong; Yanglu Zhao; Ruben G W Quek; Roger S Blumenthal; Matthew J Budoff; Mary Cushman; Parveen Garg; Veit Sandfort; Michael Tsai; J Antonio G Lopez
Journal:  J Clin Lipidol       Date:  2017-06-30       Impact factor: 4.766

Review 4.  Lipoprotein-associated phospholipase A2: The story continues.

Authors:  Fubao Huang; Kai Wang; Jianhua Shen
Journal:  Med Res Rev       Date:  2019-05-29       Impact factor: 12.944

5.  Genome-wide association study of Lp-PLA(2) activity and mass in the Framingham Heart Study.

Authors:  Sunil Suchindran; David Rivedal; John R Guyton; Tom Milledge; Xiaoyi Gao; Ashlee Benjamin; Jennifer Rowell; Geoffrey S Ginsburg; Jeanette J McCarthy
Journal:  PLoS Genet       Date:  2010-04-29       Impact factor: 5.917

Review 6.  Lp-PLA2 Inhibition-The Atherosclerosis Panacea?

Authors:  Mahir Karakas; Wolfgang Koenig
Journal:  Pharmaceuticals (Basel)       Date:  2010-04-29

7.  A previously unreported impact of a PLA2G7 gene polymorphism on the plasma levels of lipoprotein-associated phospholipase A2 activity and mass.

Authors:  Yue Qi; Dong Zhao; Zhangrong Jia; Wei Wang; Miao Wang; Jiayi Sun; Jun Liu; Yan Li; Wuxiang Xie; Jing Liu
Journal:  Sci Rep       Date:  2016-12-01       Impact factor: 4.379

8.  Quantile-Specific Heritability of Inflammatory and Oxidative Stress Biomarkers Linked to Cardiovascular Disease.

Authors:  Paul T Williams
Journal:  J Inflamm Res       Date:  2022-01-05
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.